Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raimon Sabate

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Natural Products|January 28, 2017
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer DrugsAlba Espargaró, Tiziana Ginex, Maria Del Mar Vadell, et al.
Biomacromolecules|January 8, 2021
Dual Effect of Prussian Blue Nanoparticles on Aβ40 Aggregation: β-Sheet Fibril Reduction and Copper Dyshomeostasis RegulationJoanna Kowalczyk, Ettore Grapsi, Alba Espargaró, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 23, 2020
Multidirectional <i>in vitro</i> and <i>in cellulo</i> studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer's diseaseNatalia Szałaj, Justyna Godyń, Jakub Jończyk, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 11, 2023
New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer's diseaseKamila Czarnecka, Małgorzata Girek, Paweł Kręcisz, et al.
Biomolecules|May 4, 2026
Synthesis and Biological Profiling of New 1,2,3,4-Tetrahydrobenzo[<i>h</i>]naphthyridine-Based Hybrids as Dual Inhibitors of β-Amyloid and Tau Aggregation with Anticholinesterase ActivityAldrick B Verano, Anna Sampietro, Ana Mallo-Abreu, et al.
Bioorganic & Medicinal Chemistry|March 29, 2025
YAT2150: Overcoming limitations of traditional amyloid dyes in aggregation studiesIrene Álvarez-Berbel, Salomé Llabrés, Òscar Domènech, et al.
European Journal of Medicinal Chemistry|July 28, 2019
A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptorsF Javier Pérez-Areales, Andreea L Turcu, Marta Barniol-Xicota, et al.
European Journal of Medicinal Chemistry|August 30, 2021
Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT<sub>6</sub> receptor with anti-aggregation properties against amyloid-beta and tauTomasz Wichur, Anna Pasieka, Justyna Godyń, et al.
Future Medicinal Chemistry|June 21, 2017
Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein-huprine hybridsFrancisco Javier Pérez-Areales, Nibal Betari, Antonio Viayna, et al.
Plos One|May 15, 2008
Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugsDéborah Tribouillard-Tanvier, Suzana Dos Reis, Fabienne Gug, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Natural Products|January 28, 2017
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer DrugsAlba Espargaró, Tiziana Ginex, Maria Del Mar Vadell, et al.
Biomacromolecules|January 8, 2021
Dual Effect of Prussian Blue Nanoparticles on Aβ40 Aggregation: β-Sheet Fibril Reduction and Copper Dyshomeostasis RegulationJoanna Kowalczyk, Ettore Grapsi, Alba Espargaró, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 23, 2020
Multidirectional <i>in vitro</i> and <i>in cellulo</i> studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer's diseaseNatalia Szałaj, Justyna Godyń, Jakub Jończyk, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 11, 2023
New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer's diseaseKamila Czarnecka, Małgorzata Girek, Paweł Kręcisz, et al.
Biomolecules|May 4, 2026
Synthesis and Biological Profiling of New 1,2,3,4-Tetrahydrobenzo[<i>h</i>]naphthyridine-Based Hybrids as Dual Inhibitors of β-Amyloid and Tau Aggregation with Anticholinesterase ActivityAldrick B Verano, Anna Sampietro, Ana Mallo-Abreu, et al.
Bioorganic & Medicinal Chemistry|March 29, 2025
YAT2150: Overcoming limitations of traditional amyloid dyes in aggregation studiesIrene Álvarez-Berbel, Salomé Llabrés, Òscar Domènech, et al.
European Journal of Medicinal Chemistry|July 28, 2019
A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptorsF Javier Pérez-Areales, Andreea L Turcu, Marta Barniol-Xicota, et al.
European Journal of Medicinal Chemistry|August 30, 2021
Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT<sub>6</sub> receptor with anti-aggregation properties against amyloid-beta and tauTomasz Wichur, Anna Pasieka, Justyna Godyń, et al.
Future Medicinal Chemistry|June 21, 2017
Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein-huprine hybridsFrancisco Javier Pérez-Areales, Nibal Betari, Antonio Viayna, et al.
Plos One|May 15, 2008
Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugsDéborah Tribouillard-Tanvier, Suzana Dos Reis, Fabienne Gug, et al.
Pageof 5